| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 726436 | 4,11-bis[[2-(methylamino)ethyl]amino]-1H-naphtho[2,3-f]indol e-5,10-dione | 0.000931492155975089 | 0.3507896 |
| NSC 746930 | Null | 0.000931492155975089 | 0.38314608 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.000931492155975116 | 0.53871126 |
| NSC 3077 | s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) | 0.000931492155975116 | 0.44303343 |
| NSC 35580 | Null | 0.00109467026514912 | 0.22328959 |
| NSC 686362 | Null | 0.00109467026514912 | 0.31317316 |
| NSC 723531 | Resveratrol-3,5-diacetate | 0.00109467026514912 | 0.063106302 |
| NSC 623527 | Pyrrolidinium, N-(5-carboxypentyl)-N- [2-[2-[3-(octadecyloxy)-2-[(pyrimidine-2yl)oxy]propyloxy] ethoxy]ethyl]-, inner salt | 0.00119931827492062 | 0.41039612 |
| NSC 740276 | 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide | 0.00119931827492062 | 0.39158342 |
| NSC 335766 | Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- | 0.00119931827492064 | 0.41321886 |